Pliant Therapeutics Provides Update on BEACON-IPF
Provided By GlobeNewswire
Last update: Jun 27, 2025
Bexotegrast development in IPF discontinued
Clinical oncology program and early-stage programs continue
Recent workforce and operational changes align with next steps
Read more at globenewswire.com
